Previous 10 | Next 10 |
Collaboration with regulatory, industry, and academic partners will support and accelerate the development and validation of workflows to conduct virtual bioequivalence studies Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the ph...
Immersive activities helped attendees globally learn and apply best practices for PBPK modeling Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, announced the successful completion of...
Dr. Lukacova’s outstanding contributions to pharmaceutical research and innovation to be recognized with seven others at AAPS PharmSci 360 Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology ...
2023-08-22 12:07:22 ET Certara ( NASDAQ: CERT ) traded lower on Tuesday after Jefferies downgraded the stock to Hold from Buy, citing a lower likelihood of growth for the health tech company in 2024. The downgrade comes after Certara ( CERT ) CFO John Gallagher painted a neg...
Elevated ALT levels during clinical trials led researchers to use quantitative systems toxicology (QST) software to better understand potential underlying mechanisms Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharm...
New functionality, models, and partner data power predictive accuracy from the industry-leading machine learning platform Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announ...
2023-07-08 05:36:05 ET Summary Simulations Plus reported a 9% increase in total revenue in Q3 2023, driven by its software segment. However, declining gross margins and rising operational costs could impact future profitability. The company's stock has performed well, with a 518% ...
2023-07-06 20:04:03 ET Simulations Plus, Inc. (SLP) Q3 2023 Earnings Conference Call July 06, 2023, 05:00 PM ET Company Participants John Wilfong - Investor Relations, Financial Profiles Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Of...
2023-07-06 16:10:37 ET Simulations Plus press release ( NASDAQ: SLP ): Q3 GAAP EPS of $0.20 in-line. Revenue of $16.23M (+8.5% Y/Y) misses by $0.1M . Software revenue increased 10% to $10.6 million, representing 65% of total revenue Services revenue increased 5...
Total revenue of $16.2 million and diluted earnings per share (EPS) of $0.20 Maintains full-year revenue guidance of $59.3 - $62.0 million (+10-15%) and EPS guidance of $0.63 - $0.67 Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and...
News, Short Squeeze, Breakout and More Instantly...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance an...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...